Prevention of chemotherapy and radiation toxicity with glutamine
Diane Savarese(University of Massachusetts Chan Medical School), Barbara Corey(University of Massachusetts Chan Medical School), Paul E. Wischmeyer(Duke University Hospital), Linda T. Vahdat(Dartmouth–Hitchcock Medical Center), Gayle Katzen Savy(Acoustic MedSystems (United States))
Cited by 239
Related Papers
Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance
|Nature|2015|1.8k
Connecting copper and cancer: from transition metal signalling to metalloplasia
|Nature reviews. Cancer|2021|1.3k
Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study
|The Lancet|2011|1.1k
Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer
|New England Journal of Medicine|2019|846
Ixabepilone Plus Capecitabine for Metastatic Breast Cancer Progressing After Anthracycline and Taxane Treatment
|Journal of Clinical Oncology|2007|483